ID GBRA1_MOUSE Reviewed; 455 AA. AC P62812; P18504; DT 16-AUG-2004, integrated into UniProtKB/Swiss-Prot. DT 16-AUG-2004, sequence version 1. DT 27-MAR-2024, entry version 167. DE RecName: Full=Gamma-aminobutyric acid receptor subunit alpha-1; DE AltName: Full=GABA(A) receptor subunit alpha-1; DE Flags: Precursor; GN Name=Gabra1; Synonyms=Gabra-1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=C57BL/6J, and DBA/2J; TISSUE=Brain; RX PubMed=1356407; RA Wang J.B., Kofuji P., Fernando J.C., Moss S.J., Huganir R.L., Burt D.R.; RT "The alpha 1, alpha 2, and alpha 3 subunits of GABAA receptors: comparison RT in seizure-prone and -resistant mice and during development."; RL J. Mol. Neurosci. 3:177-184(1992). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=1848528; DOI=10.1016/0888-7543(91)90272-g; RA Keir W.J., Kozak C.A., Chakraborti A., Deitrich R.A., Sikela J.M.; RT "The cDNA sequence and chromosomal location of the murine GABAA alpha 1 RT receptor gene."; RL Genomics 9:390-395(1991). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=BALB/cJ; RX PubMed=12106288; DOI=10.1111/j.1460-9568.1990.tb00460.x; RA Kato K.; RT "A collection of cDNA clones with specific expression patterns in mouse RT brain."; RL Eur. J. Neurosci. 2:704-711(1990). RN [4] RP INTERACTION WITH TRAK1, AND SUBCELLULAR LOCATION. RX PubMed=16380713; DOI=10.1038/ng1715; RA Gilbert S.L., Zhang L., Forster M.L., Anderson J.R., Iwase T., Soliven B., RA Donahue L.R., Sweet H.O., Bronson R.T., Davisson M.T., Wollmann R.L., RA Lahn B.T.; RT "Trak1 mutation disrupts GABA(A) receptor homeostasis in hypertonic mice."; RL Nat. Genet. 38:245-250(2006). RN [5] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [6] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=25348603; DOI=10.1038/npp.2014.292; RA Swanson A.M., Allen A.G., Shapiro L.P., Gourley S.L.; RT "GABAAalpha1-mediated plasticity in the orbitofrontal cortex regulates RT context-dependent action selection."; RL Neuropsychopharmacology 40:1027-1036(2015). RN [7] RP SUBCELLULAR LOCATION. RX PubMed=25579817; DOI=10.1016/j.str.2014.11.016; RA Delto C.F., Heisler F.F., Kuper J., Sander B., Kneussel M., Schindelin H.; RT "The LisH motif of muskelin is crucial for oligomerization and governs RT intracellular localization."; RL Structure 23:364-373(2015). RN [8] RP FUNCTION, GLYCOSYLATION, AND DOMAIN EXTRACELLULAR. RX PubMed=27129275; DOI=10.1074/jbc.m116.714790; RA Brown L.E., Nicholson M.W., Arama J.E., Mercer A., Thomson A.M., RA Jovanovic J.N.; RT "Gamma-aminobutyric acid type A (GABAA) receptor subunits play a direct RT structural role in synaptic contact formation via their N-terminal RT extracellular domains."; RL J. Biol. Chem. 291:13926-13942(2016). RN [9] RP INTERACTION WITH SHISA7. RX PubMed=31601770; DOI=10.1126/science.aax5719; RA Han W., Li J., Pelkey K.A., Pandey S., Chen X., Wang Y.X., Wu K., Ge L., RA Li T., Castellano D., Liu C., Wu L.G., Petralia R.S., Lynch J.W., RA McBain C.J., Lu W.; RT "Shisa7 is a GABAA receptor auxiliary subunit controlling benzodiazepine RT actions."; RL Science 366:246-250(2019). CC -!- FUNCTION: Ligand-gated chloride channel which is a component of the CC heteropentameric receptor for GABA, the major inhibitory CC neurotransmitter in the brain (PubMed:27129275). Plays an important CC role in the formation of functional inhibitory GABAergic synapses in CC addition to mediating synaptic inhibition as a GABA-gated ion channel CC (PubMed:27129275). The gamma2 subunit is necessary but not sufficient CC for a rapid formation of active synaptic contacts and the synaptogenic CC effect of this subunit is influenced by the type of alpha and beta CC subunits present in the receptor pentamer (PubMed:27129275). The CC alpha1/beta2/gamma2 receptor and the alpha1/beta3/gamma2 receptor CC exhibit synaptogenic activity (PubMed:27129275). GABRA1-mediated CC plasticity in the orbitofrontal cortex regulates context-dependent CC action selection (PubMed:25348603). Functions also as histamine CC receptor and mediates cellular responses to histamine (By similarity). CC {ECO:0000250|UniProtKB:P62813, ECO:0000269|PubMed:25348603, CC ECO:0000269|PubMed:27129275}. CC -!- ACTIVITY REGULATION: Allosterically activated by benzodiazepines, the CC neuroanesthetic alphaxalone and pentobarbital (By similarity). CC Inhibited by the antagonist bicuculline (By similarity). CC {ECO:0000250|UniProtKB:P14867, ECO:0000250|UniProtKB:P62813}. CC -!- SUBUNIT: Heteropentamer, formed by a combination of alpha, beta, gamma, CC delta and rho chains (By similarity). Interacts with UBQLN1 (By CC similarity). Interacts with TRAK1 (PubMed:16380713). Interacts with CC KIF21B (By similarity). Identified in a complex of 720 kDa composed of CC LHFPL4, NLGN2, GABRA1, GABRB2, GABRG2 and GABRB3 (By similarity). CC Interacts with LHFPL4 (By similarity). Interacts with NLGN2 (By CC similarity). Interacts with SHISA7; interaction leads to the regulation CC of GABA(A) receptor trafficking, channel deactivation kinetics and CC pharmacology (PubMed:31601770). {ECO:0000250|UniProtKB:P14867, CC ECO:0000250|UniProtKB:P62813, ECO:0000269|PubMed:16380713, CC ECO:0000269|PubMed:31601770}. CC -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane CC {ECO:0000250|UniProtKB:P08219}; Multi-pass membrane protein CC {ECO:0000255}. Cell membrane {ECO:0000269|PubMed:16380713, CC ECO:0000269|PubMed:25579817}; Multi-pass membrane protein CC {ECO:0000255}. Cytoplasmic vesicle membrane CC {ECO:0000250|UniProtKB:P62813}. CC -!- DOMAIN: The extracellular domain contributes to synaptic contact CC formation. {ECO:0000269|PubMed:27129275}. CC -!- PTM: Glycosylated. {ECO:0000269|PubMed:27129275}. CC -!- DISRUPTION PHENOTYPE: Gene knockdown in orbitofrontal prefrontal cortex CC results in an inability of mice to select actions based on their CC consequences, developing instead habit-like behavioral inflexibility. CC {ECO:0000269|PubMed:25348603}. CC -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family. CC Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily. GABRA1 sub- CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M86566; AAB59634.1; -; mRNA. DR EMBL; M63436; AAA37654.1; -; mRNA. DR EMBL; X61430; CAA43672.1; -; mRNA. DR CCDS; CCDS24553.1; -. DR PIR; A39062; A39062. DR RefSeq; NP_034380.1; NM_010250.5. DR RefSeq; XP_006532259.1; XM_006532196.3. DR RefSeq; XP_017169748.1; XM_017314259.1. DR RefSeq; XP_017169749.1; XM_017314260.1. DR PDB; 5OSA; X-ray; 2.75 A; A/B/C/D/E=250-338, A/B/C/D/E=417-455. DR PDB; 5OSB; X-ray; 3.80 A; A/B/C/D/E=250-338, A/B/C/D/E=417-455. DR PDB; 5OSC; X-ray; 3.10 A; A/B/C/D/E=250-338, A/B/C/D/E=417-455. DR PDB; 8FOI; EM; 2.50 A; A/C=1-455. DR PDB; 8G4N; EM; 2.67 A; A/C=1-455. DR PDB; 8G4O; EM; 3.06 A; A/C=1-455. DR PDB; 8G4X; EM; 2.56 A; A=1-455. DR PDB; 8G5F; EM; 2.64 A; C=1-455. DR PDB; 8G5G; EM; 2.94 A; A=1-455. DR PDB; 8G5H; EM; 2.89 A; C=1-455. DR PDBsum; 5OSA; -. DR PDBsum; 5OSB; -. DR PDBsum; 5OSC; -. DR PDBsum; 8FOI; -. DR PDBsum; 8G4N; -. DR PDBsum; 8G4O; -. DR PDBsum; 8G4X; -. DR PDBsum; 8G5F; -. DR PDBsum; 8G5G; -. DR PDBsum; 8G5H; -. DR AlphaFoldDB; P62812; -. DR EMDB; EMD-29350; -. DR EMDB; EMD-29727; -. DR EMDB; EMD-29728; -. DR EMDB; EMD-29733; -. DR EMDB; EMD-29741; -. DR EMDB; EMD-29742; -. DR EMDB; EMD-29743; -. DR SMR; P62812; -. DR BioGRID; 199797; 32. DR ComplexPortal; CPX-2979; GABA-A receptor, alpha-1/beta-2/gamma-2. DR ComplexPortal; CPX-2983; GABA-A receptor, alpha-1/beta-3/gamma-2. DR DIP; DIP-32219N; -. DR IntAct; P62812; 1. DR STRING; 10090.ENSMUSP00000020707; -. DR BindingDB; P62812; -. DR ChEMBL; CHEMBL3139; -. DR DrugCentral; P62812; -. DR TCDB; 1.A.9.5.16; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family. DR GlyConnect; 2320; 7 N-Linked glycans (1 site). DR GlyCosmos; P62812; 2 sites, 7 glycans. DR GlyGen; P62812; 3 sites, 7 N-linked glycans (1 site), 1 O-linked glycan (1 site). DR iPTMnet; P62812; -. DR PhosphoSitePlus; P62812; -. DR SwissPalm; P62812; -. DR PaxDb; 10090-ENSMUSP00000020707; -. DR PeptideAtlas; P62812; -. DR ProteomicsDB; 272940; -. DR ABCD; P62812; 2 sequenced antibodies. DR Antibodypedia; 4533; 557 antibodies from 44 providers. DR DNASU; 14394; -. DR Ensembl; ENSMUST00000020707.12; ENSMUSP00000020707.6; ENSMUSG00000010803.14. DR Ensembl; ENSMUST00000205546.2; ENSMUSP00000146133.2; ENSMUSG00000010803.14. DR GeneID; 14394; -. DR KEGG; mmu:14394; -. DR UCSC; uc007imf.2; mouse. DR AGR; MGI:95613; -. DR CTD; 2554; -. DR MGI; MGI:95613; Gabra1. DR VEuPathDB; HostDB:ENSMUSG00000010803; -. DR eggNOG; KOG3642; Eukaryota. DR GeneTree; ENSGT00940000159136; -. DR HOGENOM; CLU_010920_2_1_1; -. DR InParanoid; P62812; -. DR OMA; YLWAYLF; -. DR OrthoDB; 4265336at2759; -. DR PhylomeDB; P62812; -. DR TreeFam; TF315453; -. DR Reactome; R-MMU-977443; GABA receptor activation. DR BioGRID-ORCS; 14394; 2 hits in 77 CRISPR screens. DR ChiTaRS; Gabra1; mouse. DR PRO; PR:P62812; -. DR Proteomes; UP000000589; Chromosome 11. DR RNAct; P62812; Protein. DR Bgee; ENSMUSG00000010803; Expressed in cerebellum lobe and 172 other cell types or tissues. DR ExpressionAtlas; P62812; baseline and differential. DR GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW. DR GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell. DR GO; GO:0032590; C:dendrite membrane; IBA:GO_Central. DR GO; GO:1902710; C:GABA receptor complex; ISO:MGI. DR GO; GO:1902711; C:GABA-A receptor complex; ISS:UniProtKB. DR GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO. DR GO; GO:0043005; C:neuron projection; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0098794; C:postsynapse; IBA:GO_Central. DR GO; GO:0099634; C:postsynaptic specialization membrane; ISO:MGI. DR GO; GO:0045202; C:synapse; IBA:GO_Central. DR GO; GO:0050809; F:diazepam binding; ISO:MGI. DR GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro. DR GO; GO:0022851; F:GABA-gated chloride ion channel activity; ISO:MGI. DR GO; GO:0005237; F:inhibitory extracellular ligand-gated monoatomic ion channel activity; IBA:GO_Central. DR GO; GO:0099507; F:ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; ISO:MGI. DR GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central. DR GO; GO:0097159; F:organic cyclic compound binding; ISO:MGI. DR GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; IDA:SynGO. DR GO; GO:0071420; P:cellular response to histamine; ISO:MGI. DR GO; GO:1902476; P:chloride transmembrane transport; ISO:MGI. DR GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; ISO:MGI. DR GO; GO:1904862; P:inhibitory synapse assembly; IDA:UniProtKB. DR GO; GO:0060078; P:regulation of postsynaptic membrane potential; IMP:SynGO. DR GO; GO:0051932; P:synaptic transmission, GABAergic; ISO:MGI. DR CDD; cd19034; LGIC_ECD_GABAAR_A1; 1. DR CDD; cd19052; LGIC_TM_GABAAR_alpha; 1. DR Gene3D; 2.70.170.10; Neurotransmitter-gated ion-channel ligand-binding domain; 1. DR Gene3D; 1.20.58.390; Neurotransmitter-gated ion-channel transmembrane domain; 1. DR InterPro; IPR006028; GABAA/Glycine_rcpt. DR InterPro; IPR001390; GABAAa_rcpt. DR InterPro; IPR005431; GABBAa1_rcpt. DR InterPro; IPR047024; Gabra-1-6_TM. DR InterPro; IPR047079; GABRA1_ECD. DR InterPro; IPR006202; Neur_chan_lig-bd. DR InterPro; IPR036734; Neur_chan_lig-bd_sf. DR InterPro; IPR006201; Neur_channel. DR InterPro; IPR036719; Neuro-gated_channel_TM_sf. DR InterPro; IPR038050; Neuro_actylchol_rec. DR InterPro; IPR006029; Neurotrans-gated_channel_TM. DR InterPro; IPR018000; Neurotransmitter_ion_chnl_CS. DR NCBIfam; TIGR00860; LIC; 1. DR PANTHER; PTHR18945:SF514; GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT ALPHA-1; 1. DR PANTHER; PTHR18945; NEUROTRANSMITTER GATED ION CHANNEL; 1. DR Pfam; PF02931; Neur_chan_LBD; 1. DR Pfam; PF02932; Neur_chan_memb; 1. DR PRINTS; PR01079; GABAARALPHA. DR PRINTS; PR01614; GABAARALPHA1. DR PRINTS; PR00253; GABAARECEPTR. DR PRINTS; PR00252; NRIONCHANNEL. DR SUPFAM; SSF90112; Neurotransmitter-gated ion-channel transmembrane pore; 1. DR SUPFAM; SSF63712; Nicotinic receptor ligand binding domain-like; 1. DR PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1. DR Genevisible; P62812; MM. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; Chloride; Chloride channel; KW Cytoplasmic vesicle; Disulfide bond; Glycoprotein; Ion channel; KW Ion transport; Ligand-gated ion channel; Membrane; KW Postsynaptic cell membrane; Receptor; Reference proteome; Signal; Synapse; KW Transmembrane; Transmembrane helix; Transport. FT SIGNAL 1..27 FT /evidence="ECO:0000255" FT CHAIN 28..455 FT /note="Gamma-aminobutyric acid receptor subunit alpha-1" FT /id="PRO_0000000429" FT TOPO_DOM 28..250 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 251..272 FT /note="Helical" FT /evidence="ECO:0000305" FT TRANSMEM 278..299 FT /note="Helical" FT /evidence="ECO:0000305" FT TRANSMEM 312..333 FT /note="Helical" FT /evidence="ECO:0000305" FT TOPO_DOM 334..420 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 421..442 FT /note="Helical" FT /evidence="ECO:0000305" FT CARBOHYD 37 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 137 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 165..179 FT /evidence="ECO:0000250" FT HELIX 37..48 FT /evidence="ECO:0007829|PDB:8G4O" FT TURN 58..62 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 65..80 FT /evidence="ECO:0007829|PDB:8G4O" FT TURN 81..84 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 85..97 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 99..101 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 108..112 FT /evidence="ECO:0007829|PDB:8G4O" FT HELIX 114..117 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 125..127 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 130..134 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 138..140 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 145..148 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 151..154 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 157..164 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 176..179 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 183..187 FT /evidence="ECO:0007829|PDB:8G4O" FT TURN 190..192 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 193..199 FT /evidence="ECO:0007829|PDB:8G4O" FT TURN 201..204 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 205..207 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 215..230 FT /evidence="ECO:0007829|PDB:8G4O" FT STRAND 235..247 FT /evidence="ECO:0007829|PDB:8G4O" FT HELIX 250..255 FT /evidence="ECO:0007829|PDB:5OSA" FT HELIX 257..269 FT /evidence="ECO:0007829|PDB:5OSA" FT HELIX 270..272 FT /evidence="ECO:0007829|PDB:5OSA" FT HELIX 278..284 FT /evidence="ECO:0007829|PDB:5OSA" FT HELIX 287..300 FT /evidence="ECO:0007829|PDB:5OSA" FT HELIX 311..335 FT /evidence="ECO:0007829|PDB:5OSA" FT HELIX 417..441 FT /evidence="ECO:0007829|PDB:5OSA" SQ SEQUENCE 455 AA; 51754 MW; A270B43423B4086E CRC64; MKKSRGLSDY LWAWTLILST LSGRSYGQPS QDELKDNTTV FTRILDRLLD GYDNRLRPGL GERVTEVKTD IFVTSFGPVS DHDMEYTIDV FFRQSWKDER LKFKGPMTVL RLNNLMASKI WTPDTFFHNG KKSVAHNMTM PNKLLRITED GTLLYTMRLT VRAECPMHLE DFPMDAHACP LKFGSYAYTR AEVVYEWTRE PARSVVVAED GSRLNQYDLL GQTVDSGIVQ SSTGEYVVMT THFHLKRKIG YFVIQTYLPC IMTVILSQVS FWLNRESVPA RTVFGVTTVL TMTTLSISAR NSLPKVAYAT AMDWFIAVCY AFVFSALIEF ATVNYFTKRG YAWDGKSVVP EKPKKVKDPL IKKNNTYAPT ATSYTPNLAR GDPGLATIAK SATIEPKEVK PETKPPEPKK TFNSVSKIDR LSRIAFPLLF GIFNLVYWAT YLNREPQLKA PTPHQ //